Description
Here are some of the uses of ATORVASTATIN (ATORVAS):
- Treatment of hypercholesterolemia
- Prevention of cardiovascular events
- Management of familial hypercholesterolemia
Sh3,000.00
ATORVASTATIN (ATORVAS) is a medication that belongs to the class of HMG-CoA reductase inhibitors or “statins”. It is used to lower cholesterol levels and reduce the risk of cardiovascular events such as heart attack and stroke.
Here are some of the uses of ATORVASTATIN (ATORVAS):
Settings | ATORVASTATIN 20MG ATORVAS remove | OFLOX OZ 200\500 MG remove | Aciclovir 200mg Tablets remove | Artemether Syrup 60ml ARH-L remove | AMBROX DROPS 15ML remove | AMBRODIL DROPS 15ML remove |
---|---|---|---|---|---|---|
Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
SKU | ||||||
Rating | ||||||
Price | Sh3,000.00 | Sh7,000.00 | Sh15,000.00 | Sh4,000.00 | Sh2,500.00 | Sh2,500.00 |
Stock | ||||||
Availability | ||||||
Add to cart | ||||||
Description | ATORVASTATIN (ATORVAS) is a medication that belongs to the class of HMG-CoA reductase inhibitors or "statins". It is used to lower cholesterol levels and reduce the risk of cardiovascular events such as heart attack and stroke. |
| Ambroxol drops are a medicine used to treat respiratory conditions that involve the production of excess mucus, such as bronchitis, chronic obstructive pulmonary disease (COPD), asthma, and other conditions that affect the lungs and airways. | |||
Content | Here are some of the uses of ATORVASTATIN (ATORVAS):
| Used to treat:
| Aciclovir 200 mg Tablets contain a medicine called aciclovir. This belongs to a group of medicines called antivirals. It works by killing or stopping the growth of viruses. | Artemether(Coartem) generic Artemether is a potent and quick-acting antimalarial agent, used for treating chloroquine-resistant falciparum malaria, including cerebral malaria. | The main uses of Ambroxol drops include:
| It is used to treat
|
Weight | ||||||
Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
Additional information |
Reviews
There are no reviews yet.